The same mammography machine can produce two very different Medicare bills. A routine screening can carry no patient cost when the provider accepts assignment, while a diagnostic exam ordered to investigate a symptom or abnormal finding generally brings 20% coinsurance after the Part B deductible. The difference is not a penalty for getting a closer look. It reflects whether Medicare is paying for preventive screening or for diagnosis, and that classification can change during one episode of care.
Medicare Prices Prevention and Diagnosis Differently
Medicare’s mammogram benefit page lists no charge for a baseline or screening mammogram when the provider accepts assignment. Part B covers a baseline exam once for women ages 35 through 39 and a screening mammogram once every 12 months for women 40 and older. Preventive coverage is designed for people without signs or symptoms requiring a diagnostic workup, which is why the statutory cost sharing is waived.
The Medicare benefit record gives a diagnostic mammogram a different financial purpose. It may be ordered after a lump, pain, discharge, skin change, or an unclear screening image raises a question. Those tests can occur more frequently than once a year when medically necessary, but after the Part B deductible the beneficiary generally pays 20% of the Medicare-approved amount. The test can be clinically similar while its billing category, frequency rules, and patient share change because the medical question has changed.
One appointment can cross the line. A facility may begin with a scheduled screening and then need extra diagnostic views or an ultrasound after the radiologist sees something that requires evaluation. The no-cost screening portion does not automatically make every added service free. That transition is why an older patient who booked a preventive exam can still receive coinsurance later without Medicare having denied the screening benefit.
Medicare’s payment rule also should not be mistaken for a universal medical recommendation. Coverage begins at the ages and intervals the program specifies, while the decision to continue screening later in life depends on health, prior findings, and a clinician’s judgment. The benefit has no simple price penalty merely because a beneficiary is older, but a medically unnecessary exam will not become appropriate solely because preventive cost sharing is waived. A prior cancer history or unresolved finding can also move the next image into diagnostic treatment even when a full year has passed.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. The free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Assignment and Follow-Up Services Shape the Final Bill
The $0 screening rule assumes the provider accepts Medicare assignment, meaning it agrees to the Medicare-approved amount as full payment for the covered service. A patient using a facility outside that arrangement may face a different result. With Original Medicare, the provider’s status can be checked before the appointment. With Medicare Advantage, network and authorization rules can add another layer even though the plan must cover the underlying preventive benefit.
The mammogram is also only one part of a possible workup. Ultrasound, magnetic resonance imaging, biopsy, pathology, and specialist visits follow their own Medicare coverage and cost-sharing rules. A no-charge screening therefore cannot be treated as a quote for the entire chain after an abnormal finding. The National Cancer Institute’s mammography fact sheet explains why additional imaging or tissue sampling may be needed and why an abnormal result is not itself a cancer diagnosis.
Supplemental insurance determines whether the 20% remains with the patient. A Medigap policy may cover Part B coinsurance according to its standardized benefits, while Medicaid or retiree coverage may also contribute. Medicare’s Medigap overview describes how those policies sit behind Original Medicare. The coverage does not alter whether a test is screening or diagnostic; it changes who ultimately pays the patient share produced by that classification.
The Order and Billing Code Carry the Cost Signal
Clinical intent is recorded in the ordering provider’s documentation and the facility’s claim. A routine order for an asymptomatic patient points toward screening, while an order tied to a symptom or prior abnormality points toward diagnosis. Older patients moving records between providers can encounter billing confusion when the order does not match the reason for the exam. The relevant financial question is not simply whether Medicare covers mammograms, but which kind of mammogram the clinician ordered.
The 12-month screening interval is also exact. Scheduling too early can move a service outside the no-cost frequency rule unless another medical reason supports diagnostic coverage. Facilities accustomed to Medicare billing can confirm the last covered screening date and the intended claim type. When extra views become necessary, a clear explanation of the new service helps distinguish legitimate diagnostic coinsurance from an improperly billed preventive exam.
Medicare’s split treatment carries a coherent policy logic: routine detection is encouraged with no cost sharing, while problem-solving tests enter the ordinary Part B cost structure. For a fixed-income patient, however, the transition can be financially abrupt. The most consequential words on the paperwork are “screening” and “diagnostic,” because they decide whether the mammogram begins at $0 or at the deductible-plus-20% formula. That classification should match the medical record.
This article was produced with AI assistance and reviewed by The Money Overview editorial team.
More Financial Reading
